CL2016002368A1 - Compounds derived from benzamide, inhibitors of wnt signaling pathways; intermediary compounds; compositions and pharmacological combinations; useful for the prevention or treatment of polyposis coli, osteoporosispseudoglioma syndrome, exudative vitreoretinopathy, retinal angiogenesis, early coronary disease, tetra amelia syndrome, type 2 diabetes mellitus, fragile syndrome, solid tumors, among others. - Google Patents
Compounds derived from benzamide, inhibitors of wnt signaling pathways; intermediary compounds; compositions and pharmacological combinations; useful for the prevention or treatment of polyposis coli, osteoporosispseudoglioma syndrome, exudative vitreoretinopathy, retinal angiogenesis, early coronary disease, tetra amelia syndrome, type 2 diabetes mellitus, fragile syndrome, solid tumors, among others.Info
- Publication number
- CL2016002368A1 CL2016002368A1 CL2016002368A CL2016002368A CL2016002368A1 CL 2016002368 A1 CL2016002368 A1 CL 2016002368A1 CL 2016002368 A CL2016002368 A CL 2016002368A CL 2016002368 A CL2016002368 A CL 2016002368A CL 2016002368 A1 CL2016002368 A1 CL 2016002368A1
- Authority
- CL
- Chile
- Prior art keywords
- syndrome
- compounds
- benzamide
- tetra
- inhibitors
- Prior art date
Links
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 title abstract 4
- 150000001875 compounds Chemical class 0.000 title abstract 4
- 101001043594 Homo sapiens Low-density lipoprotein receptor-related protein 5 Proteins 0.000 title abstract 2
- 102100021926 Low-density lipoprotein receptor-related protein 5 Human genes 0.000 title abstract 2
- 206010028980 Neoplasm Diseases 0.000 title abstract 2
- 230000004156 Wnt signaling pathway Effects 0.000 title abstract 2
- 208000029664 classic familial adenomatous polyposis Diseases 0.000 title abstract 2
- 208000029078 coronary artery disease Diseases 0.000 title abstract 2
- 201000006902 exudative vitreoretinopathy Diseases 0.000 title abstract 2
- 239000003112 inhibitor Substances 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 201000001937 osteoporosis-pseudoglioma syndrome Diseases 0.000 title abstract 2
- 230000000144 pharmacologic effect Effects 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 title abstract 2
- 230000004263 retinal angiogenesis Effects 0.000 title abstract 2
- 208000011580 syndromic disease Diseases 0.000 title abstract 2
- 208000022345 tetraamelia syndrome Diseases 0.000 title abstract 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 title abstract 2
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Compuestos derivados de benzamida, inhibidores de las vías de señalización de WNT; compuestos intermediarios; composiciones y combinaciones farmacológicas; útiles para la prevención o tratamiento de poliposis coli, síndrome de osteoporosispseudoglioma, vitreorretinopatía exudativa, angiogénesis retinal, enfermedad coronaria temprana, síndrome tetra Amelia, diabetes mellitus tipo 2, síndrome de frágil, tumores sólidos, entre otras.Compounds derived from benzamide, inhibitors of WNT signaling pathways; intermediary compounds; compositions and pharmacological combinations; useful for the prevention or treatment of polyposis coli, osteoporosispseudoglioma syndrome, exudative vitreoretinopathy, retinal angiogenesis, early coronary disease, tetra Amelia syndrome, type 2 diabetes mellitus, fragile syndrome, solid tumors, among others.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461968172P | 2014-03-20 | 2014-03-20 | |
| EP14185274 | 2014-09-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2016002368A1 true CL2016002368A1 (en) | 2017-03-03 |
Family
ID=65628886
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2016002368A CL2016002368A1 (en) | 2014-03-20 | 2016-09-20 | Compounds derived from benzamide, inhibitors of wnt signaling pathways; intermediary compounds; compositions and pharmacological combinations; useful for the prevention or treatment of polyposis coli, osteoporosispseudoglioma syndrome, exudative vitreoretinopathy, retinal angiogenesis, early coronary disease, tetra amelia syndrome, type 2 diabetes mellitus, fragile syndrome, solid tumors, among others. |
Country Status (5)
| Country | Link |
|---|---|
| CL (1) | CL2016002368A1 (en) |
| IL (1) | IL247327A0 (en) |
| MA (1) | MA39762A (en) |
| SV (1) | SV2016005282A (en) |
| ZA (1) | ZA201605726B (en) |
-
2015
- 2015-03-18 MA MA039762A patent/MA39762A/en unknown
-
2016
- 2016-08-17 ZA ZA201605726A patent/ZA201605726B/en unknown
- 2016-08-17 IL IL247327A patent/IL247327A0/en unknown
- 2016-09-20 SV SV2016005282A patent/SV2016005282A/en unknown
- 2016-09-20 CL CL2016002368A patent/CL2016002368A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SV2016005282A (en) | 2018-12-05 |
| MA39762A (en) | 2017-01-25 |
| IL247327A0 (en) | 2016-09-29 |
| ZA201605726B (en) | 2019-11-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1121938T1 (en) | 4-HYDROXY-3-(HETERORYL)PYRIDINO-2-ONE APJ AGENTS FOR USE IN THE TREATMENT OF CARDIAC DISORDERS | |
| CO2019000386A2 (en) | Heterocyclic compounds as immunomodulators | |
| MX2018003161A (en) | Methods for treating arenaviridae and coronaviridae virus infections. | |
| EA201692177A1 (en) | CONNECTIONS AND COMPOSITIONS AS AN AGONISTS OF TOLL-LIKE RECEPTOR 7 | |
| MX2016014308A (en) | COMPOUNDS AND COMPOSITIONS AS AGENTS OF THE TOLL TYPE RECEIVER 7. | |
| CR20160456A (en) | FIBERATED BIBYCLIC HETEROARILE OR ARILO COMPOUNDS | |
| TN2018000369A1 (en) | AROMATIC SULFONAMIDE DERIVATIVES. | |
| MX377916B (en) | 4-AMINO-IMIDAZOQUINOLINE COMPOUNDS. | |
| MX2017002670A (en) | Glycosidase inhibitors. | |
| MX372997B (en) | AMINOPYRIMIDINE COMPOUNDS AS JAK INHIBITORS. | |
| CL2015000880A1 (en) | Heterocyclic compounds derived from 4-pyrimidinone, hiv reverse transcriptase inhibitors; pharmaceutical composition; use in the prophylaxis or treatment of hiv infection or for the prophylaxis, treatment or delay of the onset of AIDS in a subject. | |
| CL2015001536A1 (en) | Compounds derived from pyridine, cannabinoid receptor agonists 2; synthesis process; its use for the treatment or prophylaxis of pain, atherosclerosis, diabetic retinopathy, myocardial infarction, stroke, among others. | |
| CL2015002529A1 (en) | Tetrahydropyrrolothiazine Compounds | |
| MX376062B (en) | MUSCARINIC RECEPTOR AGONISTS. | |
| MX2017006224A (en) | Heterocyclic derivatives and use thereof. | |
| UY37182A (en) | INDOLINA DERIVATIVES REPLACED AS INHIBITORS OF THE VIRAL REPLICATION OF DENGUE | |
| CL2015001279A1 (en) | Compounds derived from pyridine, urate transporter inhibitors urat 1; pharmaceutical composition that includes them; use for the treatment or prevention of diseases such as gout, hyperuricemia, hypertension, kidney diseases, among others. | |
| MX2021011507A (en) | PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS. | |
| MX389724B (en) | PHENYL-2-HYDROXY-ACETYLAMINO-2-METHYL-PHENYL COMPOUNDS | |
| MX2016013801A (en) | MODULATORS OF THE RECEPTOR COUPLED TO PROTEIN G 40 (GPR40) OF PIRROLIDINE FOR THE TREATMENT OF DISEASES LIKE DIABETES. | |
| EA201790519A1 (en) | THERAPEUTIC CONNECTIONS AS INTEGRATORS OF OREXIN-1 RECEPTOR | |
| UY36145A (en) | Compounds of 1, 3, 4-thiadiazole and use thereof for the treatment of cancer | |
| CU20200038A7 (en) | COMPOUNDS DERIVED FROM PYRAZOLO-PIRROLO-PYRIMIDINE-DIONA AS INHIBITORS OF P2X3 | |
| UY37466A (en) | N-HYDROXIAMIDINHETEROCICLES SUBSTITUTED AS MODULATORS OF INDOLAMINE 2,3-DIOXYGENASE | |
| CL2015003195A1 (en) | Purine derivatives as cb2 receptor agonists. |